Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Current landscape and clinical progress of targeted alpha radioimmunotherapy

American Journal of Nuclear Medicine and Molecular Imaging(2025)10.62347/getq4987Source: DataRank Database

Current landscape and clinical progress of targeted alpha radioimmunotherapy is a research paper published in American Journal of Nuclear Medicine and Molecular Imaging (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 0.00)OA: bronzeTopics (19)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (1)

Owen C. Booth ORCID

Live enrichment

PubMed:41567834 PMC:PMC12816825 OpenAlex:https://openalex.org/W7117729143

National Institutes of Health

Grant: 5UL1TR002529-02

Indiana Clinical and Translational Sciences Institute

FWCI

0.00

Citation Percentile

0.6%

bronzeLicense: cc-by-nc-nd

journalhttps://doi.org/10.62347/getq4987

publisherhttps://doi.org/10.62347/getq4987

repositoryhttps://pubmed.ncbi.nlm.nih.gov/41567834

repositoryhttps://hdl.handle.net/1805/52957

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12816825/

Fields of Study

Radiopharmaceutical Chemistry and ApplicationsNeuroendocrine Tumor Research AdvancesPeptidase Inhibition and Analysis03 medical and health sciences0302 clinical medicine

Keywords

RadioimmunotherapyMyeloid leukemiaCancerAntibody therapyRadiation therapyProstate cancerTargeted therapyAntibodymonoclonal antibodies (MAbs)Hematologic MalignanciesSolid TumorsΑ-emitting RadionuclidesAlpha Radioimmunotherapy (Α-rit)Review Article

Sustainable Development Goals

SDG 0: Good health and well-being

Current landscape and clinical progress of targeted alpha radioimmunotherapy

FAIR Checklist

Authors (1)

Funding (1 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)